In the current study, we investigated the role of NF-κB in the well-established Pdx1-Cre; KRASG12D; p53fl/fl (KPC) mouse model, where a combination of constitutively active KRAS and p53 deletion strongly accelerates the development of pancreatic cancer. Here, NFKB1 is linked to pancreatic neoplasm.